Principal stratum strategy: Potential role in drug development. (23rd February 2021)
- Record Type:
- Journal Article
- Title:
- Principal stratum strategy: Potential role in drug development. (23rd February 2021)
- Main Title:
- Principal stratum strategy: Potential role in drug development
- Authors:
- Bornkamp, Björn
Rufibach, Kaspar
Lin, Jianchang
Liu, Yi
Mehrotra, Devan V.
Roychoudhury, Satrajit
Schmidli, Heinz
Shentu, Yue
Wolbers, Marcel - Abstract:
- Abstract: A randomized trial allows estimation of the causal effect of an intervention compared to a control in the overall population and in subpopulations defined by baseline characteristics. Often, however, clinical questions also arise regarding the treatment effect in subpopulations of patients, which would experience clinical or disease related events post‐randomization. Events that occur after treatment initiation and potentially affect the interpretation or the existence of the measurements are called intercurrent events in the ICH E9(R1) guideline. If the intercurrent event is a consequence of treatment, randomization alone is no longer sufficient to meaningfully estimate the treatment effect. Analyses comparing the subgroups of patients without the intercurrent events for intervention and control will not estimate a causal effect. This is well known, but post‐hoc analyses of this kind are commonly performed in drug development. An alternative approach is the principal stratum strategy, which classifies subjects according to their potential occurrence of an intercurrent event on both study arms. We illustrate with examples that questions formulated through principal strata occur naturally in drug development and argue that approaching these questions with the ICH E9(R1) estimand framework has the potential to lead to more transparent assumptions as well as more adequate analyses and conclusions. In addition, we provide an overview of assumptions required forAbstract: A randomized trial allows estimation of the causal effect of an intervention compared to a control in the overall population and in subpopulations defined by baseline characteristics. Often, however, clinical questions also arise regarding the treatment effect in subpopulations of patients, which would experience clinical or disease related events post‐randomization. Events that occur after treatment initiation and potentially affect the interpretation or the existence of the measurements are called intercurrent events in the ICH E9(R1) guideline. If the intercurrent event is a consequence of treatment, randomization alone is no longer sufficient to meaningfully estimate the treatment effect. Analyses comparing the subgroups of patients without the intercurrent events for intervention and control will not estimate a causal effect. This is well known, but post‐hoc analyses of this kind are commonly performed in drug development. An alternative approach is the principal stratum strategy, which classifies subjects according to their potential occurrence of an intercurrent event on both study arms. We illustrate with examples that questions formulated through principal strata occur naturally in drug development and argue that approaching these questions with the ICH E9(R1) estimand framework has the potential to lead to more transparent assumptions as well as more adequate analyses and conclusions. In addition, we provide an overview of assumptions required for estimation of effects in principal strata. Most of these assumptions are unverifiable and should hence be based on solid scientific understanding. Sensitivity analyses are needed to assess robustness of conclusions. … (more)
- Is Part Of:
- Pharmaceutical statistics. Volume 20:Number 4(2021)
- Journal:
- Pharmaceutical statistics
- Issue:
- Volume 20:Number 4(2021)
- Issue Display:
- Volume 20, Issue 4 (2021)
- Year:
- 2021
- Volume:
- 20
- Issue:
- 4
- Issue Sort Value:
- 2021-0020-0004-0000
- Page Start:
- 737
- Page End:
- 751
- Publication Date:
- 2021-02-23
- Subjects:
- causal inference -- estimand -- intercurrent event -- potential outcomes -- randomization
Pharmacy -- Statistical methods -- Periodicals
Pharmacy -- Statistics -- Periodicals
615.10727 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/pst.2104 ↗
- Languages:
- English
- ISSNs:
- 1539-1604
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6444.125000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 17532.xml